PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

Government publishes England’s rare diseases priorities for 2023 6 Mar 2023

 

The UK government has published a report outlining progress on the Rare Disease Action Plan 2022, as well as details of the priorities of the Rare Disease Framework for 2023. 

 The ‘England Rare Diseases Action Plan 2023’ highlights recent improvements to newborn screening to speed early diagnosis, as well as clinical research by Genomics England that is providing new diagnoses and supporting further care, plus the approval of new treatments. 

 The 2023 plan lists 13 new actions to improve rare disease diagnosis and treatment, along with funding totalling over £800 million to support them. Plans include: increasing data sharing between NHS England, the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) and Genomics England; improving rare disease service commissioning; addressing health inequalities, and encouraging participation in clinical research. 

 Funding includes investments of nearly £790 million into Biomedical Research Centres, and a £12 million UK Rare Disease Research Platform. 

 Read the full report here. 

GeneralCategories

  • No categories

GeneralTags

#ABPI #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EMA #EU #FDA #innovation #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #medtech #mentalhealth #mhra #NHS #NICE #outsourcing #pharmaregulation #pharmatrends #pre-eclampsia #R&D #raredisease #rarediseases #regulation #regulatory #UKgovernment #ukpharma #ukregulation #VPAS @PPharmamedic AI Biotech COVID-19 Healthcare Medical Affairs medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital